Quantum, Real Estate, and Maryland’s Opportunity: Travis McCready on What Comes Next
Release Date: 08/16/2026
BioTalk with Rich Bendis
In this episode of BioTalk with Rich Bendis, Travis McCready, Head of Industries, Leasing Advisory at JLL, joins the conversation to discuss quantum computing, why real estate professionals are paying attention, and what this emerging technology could mean for regions like the BioHealth Capital Region. Travis explains that quantum computing should be understood as an enabling technology, much like earlier waves of innovation that helped shape new industries, companies, and regional economies. While the field is still developing, he discusses why quantum is no longer just a distant concept and...
info_outlineBioTalk with Rich Bendis
In this episode of BioTalk with Rich Bendis, Rebecca “Becky” Fisher, PhD, Deputy Director for Program Management at the Congressionally Directed Medical Research Programs, joins the conversation to help listeners better understand one of the federal biomedical research funding pathways that may be less familiar to many entrepreneurs, researchers, and life science companies. Dr. Fisher explains how CDMRP works, how it differs from and complements other federal funders such as NIH and ARPA-H, and why its mission is focused on advancing high-impact research that can lead to cures, improved...
info_outlineBioTalk with Rich Bendis
In this episode of BioTalk with Rich Bendis, Sara Dauber, Vice President, Startup Banking for J.P. Morgan’s Innovation Economy team, joins the conversation to discuss how early-stage life science and healthcare companies can think more strategically about banking, financing readiness, and long-term growth. Sara shares how her career moved from life science operating companies to NIH and now to J.P. Morgan, where she works with early-stage life science and healthcare ventures across the DMV and surrounding regions. Drawing on her experience inside startups, supporting SBIR-funded...
info_outlineBioTalk with Rich Bendis
In this episode of BioTalk with Rich Bendis, Jeffrey N. Hausfeld, M.D., Chairman of the Board and Chief Medical Officer of BioFactura Inc., and Darryl Sampey, Ph.D., President and Chief Executive Officer of Capitol Biologics, join the conversation to discuss the launch of Capitol Biologics as BioFactura’s CDMO division. Jeff and Darryl explain how BioFactura’s experience building biologics development and clinical manufacturing capabilities created the foundation for a more personalized CDMO model. The discussion explores the gap Capitol Biologics is designed to fill for emerging biotech...
info_outlineBioTalk with Rich Bendis
In this episode of BioTalk with Rich Bendis, Neal Piper, Founder and CEO of Luminoah, returns to share a major milestone in the company’s journey: FDA clearance for Luminoah Flow. A past winner of the BioHealth Capital Region Crab Trap Competition, Neal first joined BioTalk to discuss the deeply personal story behind the company. His family’s experience during his son Noah’s cancer treatment revealed the daily challenges of tube feeding, from limited mobility and caregiver burden to the lack of real-time data once patients leave the hospital. Now, after six years of development,...
info_outlineBioTalk with Rich Bendis
In this episode of BioTalk with Rich Bendis, Sam Gussman-Toh, Portfolio Manager for the Small Business Program at ARPA-H, joins the conversation to discuss how the agency is creating new pathways for small businesses developing ambitious health technologies. Sam explains how the ARPA-H model differs from traditional federal funding programs, with a focus on moonshot health solutions, program manager-led portfolios, milestone-driven contracts, and a strong emphasis on moving technologies toward real-world use. He also discusses how the Small Business Program supports SBIR and STTR performers...
info_outlineBioTalk with Rich Bendis
In this episode of BioTalk with Rich Bendis, Jared Smith, MBA, CEcD, President and CEO of the Montgomery County Economic Development Corporation, joins the conversation to discuss his new role leading economic development efforts in one of the nation’s most important biohealth markets. Jared shares how his experience in Louisiana and Nevada shaped his approach to economic development, including the importance of diversification, business retention, workforce strategy, and bringing partners together around shared goals. He also explains MCEDC’s role as a public-private partnership and how...
info_outlineBioTalk with Rich Bendis
In this episode of BioTalk with Rich Bendis, Ellen D. Harpel, Ph.D., Founder of Smart Incentives, joins the conversation to explore a topic that has shaped the growth of the BioHealth Capital Region but has rarely been discussed directly on the podcast: economic development incentives. Ellen explains why state and local governments use incentives, how they influence business location and expansion decisions, and why effective programs need clear goals, active management, performance measures, and public accountability. The discussion looks at how incentives support companies across the full...
info_outlineBioTalk with Rich Bendis
How do universities move promising discoveries out of the lab and into the market? In this episode of BioTalk, Tatiana Litvin-Vechnyak, Vice President of Georgetown’s Office of Technology Commercialization, Christon Hill, Program Manager for Georgetown Tech Ventures, and Jennifer Butler, Entrepreneur-in-Residence with BioHealth Innovation, discuss how Georgetown is building a stronger pipeline from academic science to startup formation. The conversation examines how Georgetown’s commercialization efforts are evolving, how GTV supports faculty founders, and why structured programming,...
info_outlineBioTalk with Rich Bendis
What does it take to build a biohealth ecosystem that can compete nationally? In this episode of BioTalk, Lisa Johnson, CEO of BioForward Wisconsin, discusses how Wisconsin helped shape the early use of the term “biohealth” and how that approach has supported the growth of its life sciences sector. Lisa shares how BioForward connects industry, academia, and government to strengthen the state’s ecosystem, along with key developments that have brought increased attention to the region, including the expansion of Eli Lilly and Company. She also reflects on Wisconsin’s designation as a...
info_outlineIn this episode of BioTalk with Rich Bendis, Travis McCready, Head of Industries, Leasing Advisory at JLL, joins the conversation to discuss quantum computing, why real estate professionals are paying attention, and what this emerging technology could mean for regions like the BioHealth Capital Region.
Travis explains that quantum computing should be understood as an enabling technology, much like earlier waves of innovation that helped shape new industries, companies, and regional economies. While the field is still developing, he discusses why quantum is no longer just a distant concept and why real estate, infrastructure, workforce, and sector-specific use cases will all play a role in determining which regions lead.
The conversation explores the industry’s most likely to benefit from quantum first, including government and cryptography, life sciences, and finance and insurance. Travis also discusses how quantum computing could support areas such as molecular modeling, materials science, complex risk modeling, and other problems that involve large numbers of interconnected variables.
Rich and Travis also look at the real estate side of quantum, including what makes quantum facilities different from traditional data centers or life sciences buildings. Travis explains why energy, vibration sensitivity, floor loads, electromagnetic shielding, a skilled workforce, and proximity to key research and industry assets all matter when regions consider quantum site selection.
The episode also focuses on Maryland’s position in the emerging quantum economy. Travis and Rich discuss the state’s strengths in life sciences, federal agencies, defense, cybersecurity, cryptography, research universities, and companies such as IonQ. Travis emphasizes that Maryland’s opportunity is not only in building quantum assets, but in translating those assets into commercial activity, workforce development, company formation, and long-term economic growth.
Editing and post-production work for this episode was provided by The Podcast Consultant.
Travis A. McCready is Head of Industries, Leasing Advisory in the Americas for JLL and Chair of the firm’s Global Life Sciences Advisory Board. In this role, he oversees brokerage and advisory work across JLL’s key global industry verticals, including life sciences, healthcare, data centers, energy, security and defense, technology, and higher education. He is also a member of JLL’s Innovation Districts Practice, providing strategic advisory services to innovation districts around the world. Travis has more than 25 years of experience leading public, private, and nonprofit ventures focused on science and technology-based real estate and innovation infrastructure. He also serves on several boards and advisory groups across the innovation, life sciences, academic, and energy sectors.